Mirjam Pargger

Mirjam Pargger

Auto-generated profile, based on publicly available information

Mirjam Pargger

Department of Cardiology and Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Switzerland; GREAT Network, Rome, Italy

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2026 in European Heart Journal
Verified
Journal Article
Closed access
NGNoemi Glarner
Noemi Glarner
CPChristian Puelacher
Christian Puelacher
DGDanielle M Gualandro
Danielle M Gualandro
MPMirjam Pargger
Mirjam Pargger
KDKoray Durak
Koray Durak
CMChristian Mueller
Christian Mueller
Background and Aims: Peri-operative myocardial infarction/injury (PMI) is a common cardiac complication following non-cardiac surgery. It remains unclear whether involvement of cardiologists in the management of patients developing PMI improves outcomes. Methods: This multicentre, prospective study included high-risk patients undergoing non-cardiac surgery, eligible for the institutional PMI active surveillance and response programme. Due to staffing constraints, cardiologist evaluation of patients with PMI was inconsistently available on weekends, on public holidays, or when care for more urgent patients had to be prioritized, allowing a comparison between patients receiving cardiologist evaluation and those who did not. The primary endpoint was major adverse cardiac events, defined as a composite of cardiovascular death, myocardial infarction, acute heart failure, and life-threatening arrhythmia at 365 days. The secondary endpoint was all-cause death at 365 days. Cox proportional hazards models were used to evaluate the association between cardiologist evaluation and outcomes. Results: Among 14 294 patients, 1048 developed PMI and were eligible for this analysis, of whom 614 patients (58.6%) received post-operative cardiologist evaluation. Baseline characteristics were similar between groups. After adjustment, cardiologist evaluation was independently associated with lower risk of major adverse cardiac events (adjusted hazard ratio .54, P = .001) and all-cause death (adjusted hazard ratio .65, P = .037) at 365 days. Sensitivity analyses confirmed these findings. Patients receiving cardiology evaluation were more likely to undergo non-invasive cardiac imaging and to receive dual antiplatelet and statin therapy. Conclusions: Cardiologist evaluation of patients with PMI following major non-cardiac surgery was associated with a reduced risk of major adverse cardiac events and all-cause mortality at 365 days after surgery, suggesting that interdisciplinary management may improve post-operative outcomes.

15 April 2024 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
NGNoemi Glarner
Noemi Glarner
CPChristian Puelacher
Christian Puelacher
DGDanielle M. Gualandro
Danielle M. Gualandro
MPMirjam Pargger
Mirjam Pargger
GHGabrielle Huré
Gabrielle Huré
KMKathrin Meissner
Kathrin Meissner

11 June 2026 in British Journal of Anaesthesia
Verified
Journal Article
Open access
FHFisnik Haziri
Fisnik Haziri
KDKoray Durak
Koray Durak
NGNoemi Glarner
Noemi Glarner
EEEmre Ergin
Emre Ergin
KBKatrin Burri-Winkler
Katrin Burri-Winkler
CMChristian Müller
Christian Müller
International clinical practice guidelines recommend discontinuing sodium-glucose cotransporter-2 inhibitors (SGLT2i) 3-4 days before surgery to prevent euglycemic diabetic ketoacidosis, chiefly on the basis of case reports/series. Whether SGLT2i discontinuation may increase the risk of postoperative cardiovascular complications is unclear. In a secondary analysis of the Basel-PMI (NCT02573532) and PMI-Vital (NCT05866874) prospective cohort studies in major noncardiac surgery, the exposure of interest was continuing, or stopping, SGLT2i in participants receiving chronic SGLT2i therapy. The primary outcome was an ordinal composite of acute heart failure hospitalisation and cardiovascular death within 90 days of surgery, adjusting for prespecified covariates. Secondary outcomes included the incidence of euglycemic diabetic ketoacidosis within 7 days. Among 451 study participants receiving SGLT2i (mean age 72 (range: 47-86) yr; 22% women), 404/451 (89.6%) had diabetes mellitus, and 166/451 (36.9%) had chronic heart failure. SGLT2i were discontinued before surgery in 393/451 (87.1%) participants (39.2% for 1 day, 34.4% for 2 days, 13.5% for ≥3 days). Cardiovascular complications occurred in 1/58 (1.7%) participants who continued SGLT2i, compared with 10/177 (5.7%) stopping for 1 day, 13/155 (8.4%) stopping for 2 days and 7/61 (11.5%) stopping for ≥3 days (P=0.011; adjusted odds ratio: 1.58 [95% confidence interval: 1.08-2.30] per discontinued day). Euglycemic diabetic ketoacidosis occurred in 1/451 participants after SGLT2i discontinuation. Perioperative SGLT2i discontinuation was associated with a substantially increased risk of 90-day cardiac complications. This suggests potential harm in current guideline recommendations; randomised controlled trials are needed to confirm these findings. NCT02573532, NCT05866874.

31 July 2025 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
KDKoray Durak
Koray Durak
KBKatrin Burri-Winkler
Katrin Burri-Winkler
GHGabrielle Huré
Gabrielle Huré
ISIvo Strebel
Ivo Strebel
JRJulia Reinhardt
Julia Reinhardt
CMChristian Müller
Christian Müller

4 April 2026 in Age and Ageing
Verified
Journal Article
Open access
EEEmre Ergin
Emre Ergin
KDKoray Durak
Koray Durak
NGNoemi Glarner
Noemi Glarner
FHFisnik Haziri
Fisnik Haziri
KBKatrin Burri-Winkler
Katrin Burri-Winkler
CMChristian Müller
Christian Müller
Background: The prognostic relevance of perioperative myocardial injury/infarction (PMI) in older patients undergoing major noncardiac surgery remains unclear, as high comorbidity burden may lessen its impact. Methods: Older patients (defined as age ≥70 years with ≥3 comorbidities, or ≥80 years) enrolled in a multicentre, prospective study of patients at increased cardiovascular risk undergoing major noncardiac surgery were analysed. The primary endpoint, all-cause mortality at 1 year, was analysed using Cox proportional hazards regression. Secondary endpoints included major adverse cardiac events (MACE) (cardiovascular death, acute myocardial infarction, life-threatening arrhythmia and acute heart failure), analysed using Fine–Grey hazard regression. All models were adjusted for prespecified confounders with PMI as a time-varying exposure. Results: Amongst 4634 older patients (median age 80 years; 42.9% women), PMI occurred in 892 patients (19.2%), which was higher than in younger patients (P < .0001). The distribution of PMI aetiologies was comparable between groups. At 1 year, all-cause mortality was 26.2% in patients with PMI and 13.2% in patients without PMI, and MACE occurred in 30% versus 13%, respectively. After multivariable adjustment, the hazard ratio of PMI was highest on postoperative day 1 (all-cause mortality: 10.5 [95% CI 4.5–24.5]; MACE: 4.4 [95% CI 3.2–5.9]), declined by day 90 (1.4 [95% CI 1.0–1.9] and 2.2 [95% CI 1.7–2.7], respectively), and persisted through 1 year. Conclusions: PMI was very common amongst older patients and associated with substantially higher 1-year risks of all-cause mortality and MACE, with greatest vulnerability observed during the initial 90 postoperative days.